Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell Carcinoma

Adaptive MR-guided radiotherapy (MRgRT) is a new treatment paradigm and its role as a non-invasive treatment option for renal cell carcinoma is evolving. The early clinical experience to date shows that real-time plan adaptation based on the daily MRI anatomy can lead to improved target coverage and...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Brian Keller, Anna M. E. Bruynzeel, Chad Tang, Anand Swaminath, Linda Kerkmeijer, William Chu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2021-05-01
Serie:	Frontiers in Oncology
Soggetti:	MR-guided radiotherapy renal cell carcinoma stereotactic body radiotherapy MR-linac image-guided radiotherapy
Accesso online:	https://www.frontiersin.org/articles/10.3389/fonc.2021.634830/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!